Congestive Heart Failure

Aastrom Enrolls First Patients In Phase 2b Clinical Trial of Ixmyelocel-TAastrom Biosciences Inc. (Nasdaq:ASTM), the developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that the first patients have been enrolled in the ixCELL-DCM clinical trial.
ISSYS Gets Patent For Wireless, Implantable Hemodynamic Pressure MonitorIntegrated Sending Systems Inc, or ISSYS as the firm calls itself for short, announced Thursday that it had been granted United States Patent 8,014,865 titled “Method for Monitoring a Physiologic Parameter of Patients with Congestive Heart Failure.”
German Patient Survives 5 Years With DuraHeart Assist DeviceAnn Arbor-based Terumo Heart Inc., a wholly owned subsidiary of Japan's Terumo Corp., Tuesday announced that a patient implanted with the DuraHeart Left Ventricular Assist System has surpassed five years of support on the mechanical circulatory support device.